Tag: antibody drugs


Artificial Intelligence for better antibody drugs: ready for prime time?

November 7, 2022

Via: Pharmaphorum

Artificial Intelligence (AI) and deep learning have already transformed several aspects of small molecule drug design. Recent advances in the area are now also impacting more complex tasks, such as design and optimisation of antibodies. As a result, 2022 saw […]


WHO Advises against Antibody Drugs for COVID-19 Patients

September 19, 2022

Via: GEN

The World Health Organization (WHO) Guideline Development Group recommended that patients with COVID-19 not receive the antibody drugs sotrovimab and casirivimab-imdevimab. The Group’s recommendation replaces previous conditional recommendations “Rapid Recommendations: A living WHO guideline on drugs for Covid-19,” published in […]

Clinical Trials, Research and Development

8 key clinical trials to watch for the rest of 2021

June 21, 2021

Via: Biopharma Dive

The first half of 2021 was historic for biotech. The Food and Drug Administration cleared the first new Alzheimer’s drug in nearly two decades, a controversial decision with far-reaching consequences. Multiple effective coronavirus vaccines and antibody drugs helped bring the […]